Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001689375-25-000035
Filing Date
2025-06-18
Accepted
2025-06-18 16:32:46
Documents
1
Period of Report
2024-05-13

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wk-form4a_1750278753.html 4/A  
1 FORM 4/A wk-form4a_1750278753.xml 4/A 6098
  Complete submission text file 0001689375-25-000035.txt   7669
Mailing Address ONE MERCK DRIVE P.O. BOX 100 WHITEHOUSE STATION X1 08889
Business Address
KIM PETER S (Reporting) CIK: 0001181180 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40969 | Film No.: 251057395

Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Issuer) CIK: 0001689375 (see all company filings)

EIN.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)